Meta Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
March 21, 2023 at 05:58 am EDT
Share
Meta Biomed Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 68,941.5 million compared to KRW 58,780.47 million a year ago. Net income was KRW 2,627.77 million compared to KRW 9,521.53 million a year ago.
Basic earnings per share from continuing operations was KRW 115 compared to KRW 416 a year ago. Diluted earnings per share from continuing operations was KRW 115. Basic earnings per share was KRW 115 compared to KRW 422 a year ago.
Meta Biomed Co., Ltd. is a Korea-based company engaged in the manufacture of medical materials and equipment for biotechnology and dental areas. The Company mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. It also distributes dental-related products.
META BIOMED CO., LTD. 